Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 256 AL 270

The Impact of Cholinesterase Inhibitors with or without Memantine on Antipsychotic Prescribing

Blaszczyk AT, Mang BH, Garza H, Mathys M.

Consult Pharm. 2018 May 1;33(5):273-282. doi: 10.4140/TCP.n.2018.273..

Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis

Cao B, Rosenblat JD, Brietzke E, Park C, Lee Y, Musial N, Pan Z, Mansur RB, McIntyre RS.

Diabetes Obes Metab. 2018 Oct;20(10):2467-2471. doi: 10.1111/dom.13373. Epub 2018 Jun 19.

Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease (Review)

Hassan M, Abbas Q, Seo SY, Shahzadi S, Al Ashwal H, Zaki N, Iqbal Z, Moustafa AA.

Mol Med Rep. 2018 Jul;18(1):639-655. doi: 10.3892/mmr.2018.9044. Epub 2018 May 22.

Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design

Devanand DP, Strickler JG, Huey ED, Crocco E, Forester BP, Husain MM, Vahia IV, Andrews H, Wall MM, Pelton GH.

Contemp Clin Trials. 2018 Aug;71:33-39. doi: 10.1016/j.cct.2018.05.019. Epub 2018 May 31.

Strategies for Continued Successful Treatment in Patients with Alzheimer's Disease: An Overview of Switching Between Pharmacological Agents

Blesa R, Toriyama K, Ueda K, Knox S, Grossberg G.

Curr Alzheimer Res. 2018;15(10):964-974. doi: 10.2174/1567205015666180613112040.

Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study

Salloway SP, Sperling R, Fox NC, Sabbagh MN, Honig LS, Porsteinsson AP, Rofael H, Ketter N, Wang D, Liu E, Carr S, Black RS, Brashear HR.

J Alzheimers Dis. 2018;64(3):689-707. doi: 10.3233/JAD-171157.

Nutritional Intervention to Prevent Alzheimer's Disease: Potential Benefits of Xanthophyll Carotenoids and Omega-3 Fatty Acids Combined

Nolan JM, Mulcahy R, Power R, Moran R, Howard AN.

J Alzheimers Dis. 2018;64(2):367-378. doi: 10.3233/JAD-180160.

Clinical Research on Alzheimer's Disease: Progress and Perspectives

Sun BL, Li WW, Zhu C, Jin WS, Zeng F, Liu YH, Bu XL, Zhu J, Yao XQ, Wang YJ.

Neurosci Bull. 2018 Dec;34(6):1111-1118. doi: 10.1007/s12264-018-0249-z. Epub 2018 Jun 28.

Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer's Disease

Ritchie CW, Khandker RK, Pike J, Black CM, Jones E, Ambegaonkar BM.

J Alzheimers Dis. 2018;64(3):899-910. doi: 10.3233/JAD-180306.

Protective roles of melatonin against the amyloid-dependent development of Alzheimer's disease: A critical review

Vincent B.

Pharmacol Res. 2018 Aug;134:223-237. doi: 10.1016/j.phrs.2018.06.011. Epub 2018 Jul 5.

Workshop on Synergies Between Alzheimer's Research and Clinical Gerontology and Geriatrics: Current Status and Future Directions

Brinkley TE, Berger M, Callahan KE, Fieo RA, Jennings LA, Morris JK, Wilkins HM, Kritchevsky SB.

J Gerontol A Biol Sci Med Sci. 2018 Aug 10;73(9):1229-1237. doi: 10.1093/gerona/gly041.

A Review on the Relationship between Tocotrienol and Alzheimer Disease

Chin KY, Tay SS.

Nutrients. 2018 Jul 9;10(7):881. doi: 10.3390/nu10070881.

A molecular approach in drug development for Alzheimer's disease

Agatonovic-Kustrin S, Kettle C, Morton DW.

Biomed Pharmacother. 2018 Oct;106:553-565. doi: 10.1016/j.biopha.2018.06.147. Epub 2018 Jul 11.

The Effects of Music Therapy on Cognition, Psychiatric Symptoms, and Activities of Daily Living in Patients with Alzheimer's Disease

Lyu J, Zhang J, Mu H, Li W, Champ M, Xiong Q, Gao T, Xie L, Jin W, Yang W, Cui M, Gao M, Li M.

J Alzheimers Dis. 2018;64(4):1347-1358. doi: 10.3233/JAD-180183.

Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study

Torosyan N, Sethanandha C, Grill JD, Dilley ML, Lee J, Cummings JL, Ossinalde C, Silverman DH.

Exp Gerontol. 2018 Oct 1;111:118-121. doi: 10.1016/j.exger.2018.07.009. Epub 2018 Jul 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias